Impruvon is a digital health company founded in 2020, headquartered in Baltimore. It focuses on automating medication management for long-term care, assisted living, and supported living settings, replacing manual processes with integrated digital workflows. The company serves providers across more than 20 states nationwide.
Its product suite includes eMAR+, a full electronic Medication Administration Record system with smart reminders and guided med passes; a Pharmacy Integration Engine providing 24/7 connectivity with over 75 pharmacy partners; one-click reporting tools for state regulatory compliance; and Smart MedBoxes, connected hardware that controls and tracks medication access. The platform has facilitated the administration of over 1 million medications, with reported reductions in medication errors of approximately 48%.
Impruvon's technical work spans connected hardware, software automation, and healthcare compliance, including HIPAA and SOC 2 standards. The company operates as a mission-driven startup with an advisory council that gives customers input into product development, alongside an IMPACT Community for sharing best practices among users. It raised an oversubscribed seed round to support its growth.
